Trial-level factors affecting accrual and completion of oncology clinical trials: A systematic review

BACKGROUND: Cancer is the second-leading cause of death in the United States. Clinical trials translate basic science discoveries into treatments needed by cancer patients. Inadequate accrual of trial participants is one of the most significant barriers to the completion of oncology clinical trials....

Descripción completa

Detalles Bibliográficos
Autores principales: Hauck, Cherie L., Kelechi, Teresa J., Cartmell, Kathleen B., Mueller, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573122/
https://www.ncbi.nlm.nih.gov/pubmed/34765799
http://dx.doi.org/10.1016/j.conctc.2021.100843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573122/
https://www.ncbi.nlm.nih.gov/pubmed/34765799
http://dx.doi.org/10.1016/j.conctc.2021.100843

Ejemplares similares